Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Identifying the Profile of Helicobacter Pylori-Negative Gastric Cancers: A Case-Only Analysis Within the Stomach Cancer Pooling (Stop) Project Publisher Pubmed



Morais S1, 2, 3 ; Peleteiro B1, 2, 3 ; Araujo N1, 2, 3 ; Malekzadeh R4 ; Ye W5 ; Plymoth A5 ; Tsugane S6 ; Hidaka A6 ; Hamada GS7 ; Lopezcarrillo L8 ; Zaridze D9 ; Maximovich D9 ; Aragones N10, 11 ; Castanovinyals G11, 12, 13, 14 Show All Authors
Authors
  1. Morais S1, 2, 3
  2. Peleteiro B1, 2, 3
  3. Araujo N1, 2, 3
  4. Malekzadeh R4
  5. Ye W5
  6. Plymoth A5
  7. Tsugane S6
  8. Hidaka A6
  9. Hamada GS7
  10. Lopezcarrillo L8
  11. Zaridze D9
  12. Maximovich D9
  13. Aragones N10, 11
  14. Castanovinyals G11, 12, 13, 14
  15. Pakseresht M4, 15, 16
  16. Ulises Hernandezramirez R17
  17. Lopezcervantes M18
  18. Leja M19, 20, 21, 22
  19. Gasenko E20, 21, 22
  20. Pourfarzi F4, 23
  21. Zhang ZF24
  22. Yu GP25
  23. Derakhshan MH4, 26
  24. Pelucchi C27
  25. Negri E27
  26. La Vecchia C27
  27. Lunet N1, 2, 3
Show Affiliations
Authors Affiliations
  1. 1. EPIUnit - Instituto de Saude Publica, Universidade do Porto, Porto, Portugal
  2. 2. Laboratorio para a Investiga c∼ao Integrativa e Translacional em Saude Populacional (ITR), Porto, Portugal
  3. 3. Departamento de Ciencias da Saude Publica e Forenses e Educac∼ao Medica, Faculdade de Medicina, Universidade do Porto, Porto, Portugal
  4. 4. Digestive Oncology Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
  6. 6. Epidemiology and Prevention Group, Center for Public Health Sciences, National Cancer Center, Tokyo, Japan
  7. 7. Nikkei Disease Prevention Center, Sao Paulo, Brazil
  8. 8. Mexico National Institute of Public Health, Morelos, Mexico
  9. 9. Department of Epidemiology and Prevention, Russian N.N. Blokhin Cancer Research Center, Moscow, Russian Federation
  10. 10. Epidemiology Section, Public Health Division, Department of Health of Madrid, Madrid, Spain
  11. 11. CIBER Epidemiologia y Salud Publica (CIBERESP), Madrid, Spain
  12. 12. Barcelona Institute for Global Health-ISGlobal, Barcelona, Spain
  13. 13. IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain
  14. 14. Universitat Pompeu Fabra (UPF), Barcelona, Spain
  15. 15. Department of Agricultural, Food and Nutritional Sciences, University of Alberta, Edmonton, AB, Canada
  16. 16. Nutritional Epidemiology Group, Centre for Epidemiology and Biostatistics, University of Leeds, Leeds, United Kingdom
  17. 17. Department of Biostatistics, Yale School of Public Health, Yale School of Medicine, New Haven, CT, United States
  18. 18. Facultad de Medicina, UNAM, Coyoacan, Mexico
  19. 19. Digestive Diseases Centre GASTRO, Riga, Latvia
  20. 20. Institute of Clinical and Preventive Medicine, University of Latvia, Riga, Latvia
  21. 21. Faculty of Medicine, University of Latvia, Riga, Latvia
  22. 22. Riga East University Hospital, Riga, Latvia
  23. 23. Digestive Disease Research Center, Ardabil University of Medical Sciences, Ardabil, Iran
  24. 24. Department of Epidemiology, UCLA Fielding School of Public Health and Jonsson Comprehensive Cancer Center, Los Angeles, CA, United States
  25. 25. Medical Informatics Center, Peking University, Peking, China
  26. 26. Institute of Cardiovascular & Medical Sciences, University of Glasgow, Glasgow, United Kingdom
  27. 27. Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy

Source: Cancer Epidemiology Biomarkers and Prevention Published:2022


Abstract

Background: The prevalence of Helicobacter pylori-negative gastric cancer (HpNGC) can be as low as 1%, when infection is assessed using more sensitive tests or considering the presence of gastric atrophy. HpNGC may share a high-risk profile contributing to the occurrence of cancer in the absence of infection.Weestimated the proportion of HpNGC, using different criteria to define infection status, and compared HpNGC and positive cases regarding gastric cancer risk factors. Methods: Cases from 12 studies from the Stomach cancer Pooling (StoP) Project providing data on H. pylori infection status determined by serologic test were included. HpNGC was reclassified as positive (eight studies) when cases presented CagA markers (four studies), gastric atrophy (six studies), or advanced stage at diagnosis (three studies), and were compared with positive cases. A two-stage approach (random-effects models) was used to pool study-specific prevalence and adjusted odds ratios (OR). Results: Among non-cardia cases, the pooled prevalence of HpNGC was 22.4% (n = 166/853) and decreased to 7.0% (n = 55) when considering CagA status; estimates for all criteria were 21.8% (n = 276/1,325) and 6.6% (n = 97), respectively. HpNGC had a family history of gastric cancer more often [OR = 2.18; 95% confidence interval (CI), 1.03-4.61] and were current smokers (OR = 2.16; 95% CI, 0.52-9.02). Conclusion: This study found a low prevalence of HpNGC, who are more likely to have a family history of gastric cancer in first-degree relatives. © 2022 American Association for Cancer Research Inc.. All rights reserved.
Other Related Docs
14. The Stomach Cancer Pooling (Stop) Project: Study Design and Presentation, European Journal of Cancer Prevention (2015)
31. Risk Factors for Gastric Cancer: A Systematic Review, Asian Pacific Journal of Cancer Prevention (2018)